GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Interest Expense (Positive)

Tevogen Bio Holdings (FRA:G28) Interest Expense (Positive)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Tevogen Bio Holdings Business Description

Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.